StockData
Impact BioMedical Inc. logo

Impact BioMedical Inc. (IBO) stock

IBONYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30
$3.06+0.38 (+14.18%)

Close on Oct 19, 2026Market cap $329.93MP/E –Yield –

Impact BioMedical cash

Cash and short-term investments held at the end of each period.

Impact BioMedical's cash was $10.00K at Jun 30, 2026. For fiscal 2025 it was $3.00K, down 99.8% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.00K-99.8%
FY2024Dec 31, 2024$2.00M+199800.0%
FY2023Dec 31, 2023$1.00K-50.0%
FY2022Dec 31, 2022$2.00K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$10.00K-98.4%
Q1 FY2026Mar 31, 2026$20.00K-98.5%
Q4 FY2025Dec 31, 2025$3.00K-99.8%
Q3 FY2025Sep 30, 2025$12.00K-99.6%
Q2 FY2025Jun 30, 2025$624.00K+31100.0%
Q1 FY2025Mar 31, 2025$1.32M+65800.0%
Q4 FY2024Dec 31, 2024$2.00M+199800.0%
Q3 FY2024Sep 30, 2024$2.67M+1227.4%
Q2 FY2024Jun 30, 2024$2.00K-33.3%
Q1 FY2024Mar 31, 2024$2.00K0.0%
Q4 FY2023Dec 31, 2023$1.00K–
Q3 FY2023Sep 30, 2023$201.00K–
Q2 FY2023Jun 30, 2023$3.00K–
Q4 FY2022Dec 31, 2022$2.00K–

More Impact BioMedical figures

See a number that looks wrong?